Sponsored by BeOne Medicines 26 Jun 2025 How can treatment strategies evolve to address the challenges in chronic lymphocytic leukemia? Learn how insights and continuous therapy are transforming chronic lymphocytic leukemia care, empowering patients to live beyond uncertainty. June 26, 2025 - 5 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
In Depth 25 Jun 2025 ALS: how close are we to a cure? Let us take a look at how the hunt for amyotrophic lateral sclerosis (ALS) drugs has advanced over the past few years. June 25, 2025 - 12 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 6 Jun 2025 Beyond CRISPR: What CAST could bring to genome editing Delve into what the new CRISPR tool, CAST, has to offer. CRISPR-associated transposases are already gaining traction in research. June 6, 2025 - 7 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
Webinars 5 May 2025AI in antibody discovery: From in silico analysis to AI-enabled data management Explore how AI and bioinformatics are reshaping antibody discovery, from in silico design to efficient data management. May 5, 2025 Share WhatsApp Twitter Linkedin Email
News and Trends 28 Apr 2025 U.S. budget cuts: what is the impact on therapeutic research? We unpack the full scope of the U.S. budget cuts, from canceled clinical trials and stalled drug approvals to mass layoffs and lawsuits. April 28, 2025 - 10 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 14 Apr 2025 Metabolomics: The study of biology’s dark matter Learn about metabolomics, biology’s fourth language that has remained vastly untapped up until now and could accelerate biotech research. April 14, 2025 - 7 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
In Depth 7 Apr 2025 Will tRNA therapy be the next big thing in genetic disease treatment? Discover how an emerging technology called tRNA therapy could become the next big thing in genetic disease treatment. April 7, 2025 - 12 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 2 Apr 2025 Beyond amyloid: The search for the next big thing in Alzheimer’s treatment Delve into how the biotech industry is pivoting from the amyloid hypothesis to find new Alzheimer’s disease treatments. April 2, 2025 - 10 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
In Depth 7 Mar 2025 Catalonia: A biotech hub going from strength to strength, with Barcelona at its core Take a deeper look at Catalonia’s biotech sector and overall life sciences hub, including the key drivers behind its success. March 7, 2025 - 9 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
Reports Produced by Inpart 3 Mar 2025R&D trends: Biotech assets & discovery platforms Inpart’s latest report provides access to the most promising biotech assets and discovery platforms, shedding light on the latest trends in biotech R&D. March 3, 2025 Share WhatsApp Twitter Linkedin Email Produced by Inpart
Best in Biotech 25 Feb 2025 Seven biotech spinouts to watch out for in 2025 Here are seven biotech spinouts to keep an eye out for this year that specialize in a number of therapeutic areas. February 25, 2025 - 9 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Best in Biotech 17 Oct 2024 Top six European biotech entrepreneurs to know in 2024 (according to VCs) We reached out to VCs to nominate prominent European entrepreneurs in the biotech industry who are committed to bringing potentially life-changing treatments to market. October 17, 2024 - 8 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email